Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation

Adrian Egli,Christoph Bucher,Alexis Dumoulin,Martin Stern,Andreas Buser,Lukas Bubendorf,M. Gregor,P. Servida,G. Sommer,J. Bremerich,A Gratwohl,Nina Khanna,Andreas F. Widmer,Manuel Battegay,Michael Tamm,Hans H. Hirsch,J. Halter

Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation

2012

Adrian Egli
Christoph Bucher
Alexis Dumoulin
Martin Stern
Andreas Buser
Lukas Bubendorf
M. Gregor
P. Servida
G. Sommer
J. Bremerich
A Gratwohl
Nina Khanna
Andreas F. Widmer
Manuel Battegay
Michael Tamm
Hans H. Hirsch
J. Halter

Background The clinical characteristics of human metapneumovirus (hMPV)-associated lower respiratory tract infection (LRTI) after allogeneic hematopoietic stem cell transplantation (HSCT) is not well described. We describe the clinical course in eight HSCT recipients suffering from hMPV infection.

Keywords:

Virology
Hematopoietic stem cell transplantation
Human metapneumovirus
Immunology
Metapneumovirus
Human metapneumovirus infection
Lower respiratory tract infection
Medicine
posttransplant infection
clinical course
respiratory virus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations